On September 28, 2017, RavenQuest Biomed Inc. (formerly, Ravencrest Resources Inc.) completed the acquisition of the specialized cannabis services business operated by the CL2G Group. CL2G provides management and advisory services to Health Canada applicants under the Access to Cannabis for Medical Producers Regulations (ACMPR). CL2G also operates a fully-equipped cannabis operations training facility, and is involved in the development of proprietary cannabis-growth technologies.
In connection with completion of the acquisition, RavenQuest completed a concurrent private placement for gross proceeds of $6,300,000.
Cassels Brock acted for CL2G with a team comprised of Jennifer Traub, Sam Cole and Aimee O’Donnell (Corporate).